Kalogon Raises $5.75M to Expand Smart Seating Across Healthcare and Defense

Kalogon, a Melbourne, Florida-based smart seating company, has raised $5.75M in funding led by Enable Ventures, with participation from Florida Opportunity Fund, Castellan Group, DeepWork Capital, Sawmill Angels, and Black Opal Ventures. The company develops adaptive seating systems that use machine learning, sensors, and air-cell technology to automatically redistribute pressure and improve circulation for people who spend extended periods seated.

Founded by Tim Balz and a team that includes former SpaceX engineers such as Evan Rosenberg, Kalogon sits at the intersection of healthcare technology, advanced manufacturing, and intelligent systems. The company's proprietary Advanced Pressure Management System (APMS) powers products including Orbiter and Orbiter Med, adaptive seating platforms designed to reduce pressure injuries and improve circulation.

The funding arrives as Kalogon reports strong commercial momentum, including medical revenue that more than tripled year over year and overall revenue that more than doubled. The company has also expanded its manufacturing footprint in Melbourne, Florida, strengthening its ability to support growing demand. The broader significance extends beyond a single funding round, as Kalogon represents a growing category of companies building technologies around human performance, health outcomes, and adaptive systems that can move across healthcare, aviation, and defense markets.

What Happened

The venture market loves a dramatic story. Founders sleeping on couches. Investors wiring money after a 20-minute meeting. Products exploding into existence overnight. Reality is usually less cinematic.

Kalogon's $5.75M funding round looks more like the version startup operators recognize: years of product development, clinical validation, manufacturing expansion, customer adoption, and then funding. The company was founded by Tim Balz, whose work with Freedom Chairs exposed him to the challenges faced by wheelchair users. That experience became the foundation for Kalogon, which set out to solve a costly and persistent healthcare problem: pressure injuries caused by prolonged sitting.

Kalogon developed its Advanced Pressure Management System, combining machine learning, sensors, and adaptive air-cell technology to continuously adjust seating pressure. The result is a platform designed to improve circulation, reduce fatigue, and protect tissue integrity. Enable Ventures, which focuses on companies addressing disability inclusion and accessibility markets, viewed Kalogon as a natural fit. Investors increasingly reward evidence over ambition, and Kalogon arrived at this round carrying both.

Why This Matters

The easiest way to misunderstand Kalogon is to think it sells cushions. The more accurate description is that Kalogon is building an intelligent seating platform, and that distinction matters.

Pressure injuries affect roughly 2.5M Americans annually and create billions of dollars in healthcare costs. For wheelchair users and others who spend significant amounts of time seated, pressure management is not a comfort issue. It is a health issue. Healthcare markets tend to reward technologies that can demonstrate measurable outcomes, and Kalogon's focus on clinical validation places it in a different category than companies selling comfort products or ergonomic accessories.

Kalogon's Medicare-coded products also position the company inside established healthcare reimbursement channels, reducing adoption friction compared with many medical technology startups. Investors often search for large markets, but the stronger signal appears when a company identifies a painful problem, develops a measurable solution, and demonstrates demand. That combination is becoming increasingly difficult to ignore.

Market Context

Healthcare is undergoing a quiet shift. For years, software captured most of the venture spotlight. Today, investors are showing renewed interest in technologies that combine software, hardware, manufacturing, and data.

Kalogon fits squarely within that trend. The company's platform collects information, adapts in real time, and continuously optimizes performance. That makes the product more than a static medical device. It becomes part of a broader movement toward intelligent physical infrastructure. The trend extends well beyond healthcare, with adaptive systems appearing across transportation, industrial environments, logistics, defense, and workplace safety.

Organizations increasingly want products that respond to conditions rather than simply exist within them. Kalogon also represents a growing wave of Florida-based deep technology companies emerging from aerospace, healthcare, and defense ecosystems. As investors look beyond traditional startup hubs, markets such as Florida continue producing companies with strong technical foundations and commercial traction.

Competitive Landscape

One of the more interesting aspects of Kalogon's strategy is not who it competes against. It is where the company is heading.

Many medical technology companies remain confined to a single reimbursement model or healthcare niche. Kalogon has already demonstrated applications beyond traditional mobility markets. The company's technology has been tested aboard B-52 aircraft, building on work supported through the U.S. Air Force SBIR program. That highlights how pressure management and fatigue reduction can create value in aviation and defense environments.

Healthcare remains the foundation, but aviation and defense create optionality. Investors tend to notice when a company begins expanding its total addressable market without abandoning its original mission.

What This Signals

The Kalogon funding round signals a broader investor appetite for companies solving physical-world problems with intelligent systems. For years, software dominated venture narratives because software scales efficiently. Now a growing number of investors are looking for technologies that connect software intelligence with measurable real-world outcomes.

Kalogon's growth metrics strengthen that narrative. The company reported medical revenue growth exceeding 3x year over year and overall revenue growth exceeding 2x. It has expanded manufacturing capacity, strengthened distribution relationships, and continued investing in clinical validation. Those are operational signals that markets eventually reward.

This funding round suggests investors believe Kalogon has built enough evidence to justify the next phase of growth while demonstrating that meaningful innovation does not always arrive wrapped in a software subscription.

The Bigger Industry Shift

The most important part of the Kalogon story may have nothing to do with wheelchairs. It may be about how innovation increasingly moves between industries.

A technology designed to improve health outcomes can eventually influence aviation. A defense application can inform healthcare. Manufacturing improvements can accelerate product adoption across multiple sectors. The walls separating industries continue getting thinner, creating opportunities for companies that understand fundamental human problems and can solve them in ways that travel beyond their original market.

Kalogon started with seating. The company is increasingly positioning itself around human performance, adaptive systems, and intelligent infrastructure. That is a much larger conversation, and one investors appear increasingly willing to fund.

Frequently Asked Questions

What is Kalogon?

Kalogon is a Melbourne, Florida-based healthcare technology company that develops smart seating systems designed to improve circulation, reduce pressure injuries, and enhance seated health outcomes.

How much funding did Kalogon raise?

Kalogon raised $5.75M in funding led by Enable Ventures.

Who invested in Kalogon's funding round?

The round included Enable Ventures, Florida Opportunity Fund, Castellan Group, DeepWork Capital, Sawmill Angels, and Black Opal Ventures.

Who founded Kalogon?

Kalogon was founded by Tim Balz alongside a team that includes former SpaceX engineers and healthcare technology innovators.

What products does Kalogon offer?

Kalogon's product portfolio includes Orbiter and Orbiter Med, which use the company's Advanced Pressure Management System to dynamically manage seating pressure and improve circulation.

Why is Kalogon expanding into aviation and defense?

The company's pressure-management technology has applications beyond healthcare, including fatigue reduction and seating optimization in aviation and defense environments.

Where is Kalogon headquartered?

Kalogon is headquartered in Melbourne, Florida.

Why does Kalogon's funding matter?

The funding reflects growing investor interest in companies combining healthcare technology, advanced manufacturing, intelligent systems, and measurable clinical outcomes.